
Invus
86 portfolio companies · 16 on the map · $3.7B raised · 13 cities · invus.com
Portfolio map
16 Invus portfolio companies on the map.
Portfolio companies

Doctolib
Paris
Doctolib is an online and mobile booking platform that helps users find doctors and make appointments.
Healthtech$866MEst. 2013Hiring fast
Scholar Rock
Cambridge
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Biotechnology$743MEst. 2012
Mission Lane
Richmond
Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.
Financial Services$675MEst. 2018
Seaport Therapeutics
Boston
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Biotechnology Research$340M
Ring Therapeutics
Cambridge
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Biotechnology Research$253.5MEst. 2017
Mirador Therapeutics
San Diego
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Biotechnology Research$250MEst. 2024
Payhawk
London
Payhawk is a platform offering global corporate cards, expense tracking, and automated payables for real‑time financial control.
Financial Services$236.1MEst. 2018
Median Technologies
Valbonne
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, screening, and clinical practice.
Software Development$235.7MEst. 2002
Klarity
San Francisco
Klarity Health provides high-quality, worry-free and low-cost telehealth services, ensuring comprehensive care is within reach. Whether you're seeking mental health support, weight management, or counseling and therapy, Klarity is your trusted marketplace for health and well-being. We have facilitated over 350,000 telehealth visits and are trusted by 80,000+ patients and 400+ medical specialists. Check out our 5-star ratings: https://www.reviews.io/company-reviews/store/helloklarity
AI Tools$88MEst. 2021
Olive
San Francisco
Olive enables companies to create internal tools by describing their needs in natural language, positioning itself as the fastest way to create internal tools. It has raised a $2.1 million seed round and is scaling its team.
SaaS$2.1M
Element Science
San Francisco
Element Science is a San Francisco-based medical device startup focused on patient-first, lifesaving devices for heart disease; its first product is funded by Google Ventures and Third Rock Ventures, blending user-centric design with medica
Medical Equipment ManufacturingSeries CEst. 2013
LEXICON PHARMACEUTICALS
The Woodlands
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
Pharmaceutical ManufacturingPublicEst. 1995KSQ Therapeutics
lexington
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Pharmaceutical ManufacturingSeries CEst. 2015
Thrive Market
Los Angeles
Thrive Market is a membership-based online company that offers natural and organic food products.
Wellness and Fitness ServicesEst. 2013
Lycia Therapeutics
South San Francisco
Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise
BiotechnologySeries CEst. 2020
ElevateBio
Waltham
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Pharmaceutical ManufacturingSeries DEst. 2017Hiring fast
More portfolio companies
68 more Invus investments we track beyond the map — 86 tracked in total.
PayJoySan Francisco · Series C
BrexSan Francisco · Venture
Triana BiomedicinesLexington · Series B
ezCaterBoston · Series D
VeraDermicsNew Haven · Series C
AbivaxParis · Post-IPO Equity
Bambusa TherapeuticsBoston · Series A
TigerConnectSanta Monica · Series D
Vigil NeuroscienceCambridge · Series B
Crinetics PharmaceuticalsSan Diego · Post-IPO Equity
AgomAb TherapeuticsAntwerpen · Series D
Pretzel TherapeuticsWaltham · Series A
Gossamer BioSan Diego · Post-IPO Equity
MOMA TherapeuticsCambridge · Series B
LifeMine TherapeuticsCambridge · Series C
SMG Swiss Marketplace GroupZürich · Seed
AmountChicago · Series D
DorsiaMiami Beach · Series A
Asher BioSan Francisco · Series B
SnagajobGlen Allen · Series D
SeerRedwood City · Series D
Flare TherapeuticsCambridge · Series B
Sagimet BiosciencesSan Mateo · Venture
SchrödingerNew York · Series E
Averna TherapeuticsBoston · Series A
BelliwelliLos Angeles · Series A
KNIMEZürich · Venture
ViseonIrvine · Series B
Zero MotorcyclesScotts Valley · Venture
Edgewise TherapeuticsBoulder · Post-IPO Equity
Evox TherapeuticsOxford · Series C
Noema PharmaBasel · Series B
City TherapeuticsCambridge · Series A
Pi HealthCambridge · Series A
Cava GroupWashington · Series F
Abata TherapeuticsCambridge · Series A
Endeavor BioMedicinesSolana Beach · Series C
ImCheck TherapeuticsMarseille · Series C
Engine BiosciencesSingapore · Series A
EscaleSão Paulo · Series C
BizagiLondon · Private Equity
Vicore PharmaMölndal · Post-IPO Equity
PatientsLikeMeBoston · Venture
AmbrxLa Jolla · Private Equity
Inventiva PharmaDaix · Post-IPO Equity
HappyVoreParis · Venture
Health Data Analytics InstituteDedham · Series C
Opera SolutionsJersey City · Private Equity
Black Diamond TherapeuticsCambridge · Series C
Taysha Gene TherapiesDallas · Post-IPO Equity
Cyclerion TherapeuticsCambridge · Post-IPO Equity
Fusion PharmaceuticalsHamilton · Post-IPO Equity
The Curious AI CompanyHelsinki · Venture
Kalaris Therapeutics (formerly AlloVir)Houston · Post-IPO Equity
Ikena OncologyBoston · Series B
Generation BioCambridge · Series C
Morphic TherapeuticWaltham · Series B
Future FinanceDublin · Series C
ITeos TherapeuticsCambridge · Series B
vTv TherapeuticsHigh Point · Post-IPO Equity
Vascular DynamicsMountain View · Venture
FlatFrog LaboratoriesLund · Venture
Oyster Point PharmaceuticalsSan Francisco · Series B
Hookipa PharmaNew York · Series D
Elixir MedicalSunnyvale · Series A
Blue BuffaloWilton · Seed
RenovisSouth San Francisco · Series E
IAM comLos Angeles · Venture
Portfolio map
16 Invus portfolio companies on the map.